Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meghan A Rice

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|September 27, 2019
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate CancerMeghan A Rice, Sanjay V Malhotra, Tanya Stoyanova
Molecular Cancer Therapeutics|April 28, 2019
Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen TherapiesMeghan A Rice, En-Chi Hsu, Merve Aslan, et al.
Cancer Research|January 23, 2021
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate CancerAli Ghoochani, En-Chi Hsu, Merve Aslan, et al.
Journal of Proteome Research|September 12, 2018
Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast CancerCatherine C Going, Dhanir Tailor, Vineet Kumar, et al.
Oncogene|November 21, 2020
Plectin is a regulator of prostate cancer growth and metastasisMark Buckup, Meghan A Rice, En-Chi Hsu, et al.
Molecular Cancer Research : MCR|August 17, 2017
Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer VulnerabilitiesFiorella Magani, Stephanie O Peacock, Meghan A Rice, et al.
NPJ Breast Cancer|October 29, 2021
Oncogene-mediated metabolic gene signature predicts breast cancer outcomeMerve Aslan, En-Chi Hsu, Fernando J Garcia-Marques, et al.
British Journal of Cancer|December 8, 2020
Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancerShiqin Liu, Michelle Shen, En-Chi Hsu, et al.
Science Translational Medicine|June 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancerNing Zhao, Stephanie O Peacock, Chen Hao Lo, et al.
Cancer Research|February 27, 2021
<i>In Vivo</i> Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk StratificationJinghang Xie, Meghan A Rice, Zixin Chen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|September 27, 2019
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate CancerMeghan A Rice, Sanjay V Malhotra, Tanya Stoyanova
Molecular Cancer Therapeutics|April 28, 2019
Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen TherapiesMeghan A Rice, En-Chi Hsu, Merve Aslan, et al.
Cancer Research|January 23, 2021
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate CancerAli Ghoochani, En-Chi Hsu, Merve Aslan, et al.
Journal of Proteome Research|September 12, 2018
Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast CancerCatherine C Going, Dhanir Tailor, Vineet Kumar, et al.
Oncogene|November 21, 2020
Plectin is a regulator of prostate cancer growth and metastasisMark Buckup, Meghan A Rice, En-Chi Hsu, et al.
Molecular Cancer Research : MCR|August 17, 2017
Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer VulnerabilitiesFiorella Magani, Stephanie O Peacock, Meghan A Rice, et al.
NPJ Breast Cancer|October 29, 2021
Oncogene-mediated metabolic gene signature predicts breast cancer outcomeMerve Aslan, En-Chi Hsu, Fernando J Garcia-Marques, et al.
British Journal of Cancer|December 8, 2020
Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancerShiqin Liu, Michelle Shen, En-Chi Hsu, et al.
Science Translational Medicine|June 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancerNing Zhao, Stephanie O Peacock, Chen Hao Lo, et al.
Cancer Research|February 27, 2021
<i>In Vivo</i> Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk StratificationJinghang Xie, Meghan A Rice, Zixin Chen, et al.
Pageof 2